Business
DOCM: Revenue up 7%, non-Rx profitable, Teleclinic doubled, CHF 200M raise planned for Rx growth
DOCM: Revenue up 7%, non-Rx profitable, Teleclinic doubled, CHF 200M raise planned for Rx growth
About this update from Docmorris Ltd
Revenue grew 7% year-over-year, with all segments contributing and non-Rx business reaching profitability. Teleclinic doubled revenues, and a CHF 200 million capital raise is planned to support Rx growth and refinance debt. Guidance will be updated post-Q1 results. Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.